Logo Image
News
All NewsFDA UpdatesPress Releases
Watch
Expert ConversationsNews & AnalysisShows & PodcastsSponsored Webcast
Conferences
Conference CoverageConference Listing
Publications
All PublicationsPharmacy TimesPharmacy Practice in Focus: OncologyPharmacy Practice in Focus: Health SystemsPharmacy CareersAuthor SubmissionSubmit to Pharmacy Practice in Focus: OncologySubmit to Pharmacy Practice in Focus: Health SystemsBecome a Peer ReviewerSupplements & Featured Publications
More
Events
Upcoming EventsUpcoming Webinars
CE
Resources
Clinical ForumAmerican Heart MonthThe Bispecifics NetworkEducated PatientInformation for the PharmacistInteractive ToolsMicrositesPartnersPulsePointSponsoredWhiteboards

Subscribe

  • News
  • Watch
  • Conferences
  • Publications
  • Events
  • CE
  • Resources
  • Subscribe
  • 503B Compounding Pharmacy
  • Allergy
    • Asthma
  • Biosimilars
  • Cardiovascular Health
    • Heart Failure
    • Cholesterol
  • Chronic Kidney Disease
  • Classical Hematology
    • Immunoglobulins
    • Neutropenia
  • Dermatology
    • Psoriasis
    • Atopic Dermatitis
  • Endocrinology
    • Continuous Glucose Monitoring
    • Diabetes
    • Osteoporosis
  • Eye Care
    • Macular Degeneration
    • Dry Eye Disease
  • Future of Pharmacy
  • Gastrointestinal Health
    • Digestive Health
  • Hematology
    • Multiple Myeloma
    • Lymphoma
    • Myelofibrosis
    • Chronic Lymphocytic Leukemia
  • Hepatitis/MASH
  • Infectious Disease
    • Respiratory Syncytial Virus
    • Pneumococcal
    • C. difficile
    • COVID-19
    • Flu
    • HIV
    • PrEP
    • COVID Treatment
  • Neurology
    • Multiple Sclerosis
    • Alzheimer Disease
    • Epilepsy
    • Migraine
    • Sleep
    • Shingles
    • Alzheimer Disease
    • Movement Disorders
    • Parkinson Disease
  • Oncology
    • Cholangiocarcinoma
    • Endometrial Cancer
    • Immuno-oncology
    • Genitourinary Cancer
    • Lung Cancer
    • Prostate Cancer
    • Skin Cancer
    • Ovarian Cancer
    • Breast Cancer
    • Cervical Cancer
    • Gastrointestinal Cancer
    • Colorectal Cancer
    • HER2 Breast Cancer
  • Pain Management
  • Pediatrics
  • Psychiatry
    • Psychedelics
    • Schizophrenia
    • ADHD
    • Brain Health
    • Mental Health
    • Bipolar Disorder
    • Anxiety
    • Depression
  • Pulmonology
    • COPD
    • Cough and Cold
  • Rheumatology
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
  • Vaccines
    • Travel Vaccines
  • Veterinary Pharmacy
  • Vitamins and Supplements
  • Weight Management
  • Women's Health
    • Reproductive Health
Spotlight -
Community/Retail|
Hospital|
Oncology|
Pharmacy Technician|
Student
Advertisement

Douglas Gebhard, PharmD, MBA

Advertisement

Articles by Douglas Gebhard, PharmD, MBA

Bridging the Gap: Field Teams and Hubs Supporting Patient Care

ByBridget Trabbold, PharmD,Michael Krzyzewski, PharmD,Douglas Gebhard, PharmD, MBA,Gordon J. Vanscoy, PharmD, MBA, CACP,Heather Len,Rocco Contristano,Daniel Paul, PharmD, MPBA
January 5th 2026

Enhanced communication between field representatives and case managers improves medication access for patients with rare diseases.

Specialty Pharmacy Today: Improving the Lives of Patients With Rare Diseases Through Orphan Drug Management

ByGordon J. Vanscoy, PharmD, MBA, CACP,Douglas Gebhard, PharmD, MBA,Jonathan Ogurchak, PharmD, CSP,Pamela Koerner, PharmD, BCPS
September 11th 2017

The specialty pharmacy marketplace has quickly become the primary dispenser of most therapies for orphan conditions.

Advertisement

Latest Updated Articles

  • Specialty Pharmacy Today: Improving the Lives of Patients With Rare Diseases Through Orphan Drug Management
    Specialty Pharmacy Today: Improving the Lives of Patients With Rare Diseases Through Orphan Drug Management

    September 11th 2017



Advertisement
Advertisement

Trending on Pharmacy Times

1

FDA Approves XFG-Adapted COVID-19 Vaccine, mRNA for the 2026-2027 Season

2

What Heidi Overton's FDA Nomination Could Mean for Pharmacy

3

FDA Approves First Oral Drug for Dermatomyositis

4

FDA Grants Fast Track Designation to Varsetatug Masetecan for Metastatic Colorectal Cancer

5

FDA Approves Bixlenvo Once-Daily Single-Tablet Regimen for Virologically Suppressed Adults With HIV

  • About Us
  • Clinical Forums
  • Advertise
  • Contact Us
  • Editorial Staff
  • Privacy Policy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contemporary Clinic
  • OTC Guide
  • Pharmacy Times
  • Pharmacist Mom's Group
  • Pharmacist Mom's Group
Pharmacy Times
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us